Curtis L  Triplitt, PharmD, CDE

With a strong interest in diabetes, I have focused for the past 21 years solely on the prevention, treatment, and research on type 2 diabetes mellitus.  For the past 20 years I have been directly involved in all aspects of type 2 diabetes mellitus research, clinical care, and education.  For diabetes research, I have been directly involved with the design, planning, implementation, budget, performance of procedures, data gathering and analysis, abstract, manuscript, presentation, and all aspects of research drug stewardship.

• Professional Background

  Education

  • 1996 - Residency - Primary Care - William S. Middleton VA Hospital
  • 1995 - PharmD - Clinical Pharmacy - UTHSCSA/University of Texas at Austin
  • 1993 - BS - Pharmacy - University of Iowa

  Appointments

  • 9/2004 - Assistant Professor/Clinical - University of Texas Health Science Center at San Antonio, Medicine, San Antonio
  • 1/1998 - Assistant Professor/Clinical - University of Texas at Austin, College of Pharmacy, Pharmacotherapy Research & Graduate Training, San Antonio
  • 1/1997 - Research Pharmacist - Texas Diabetes InstituteSan Antonio

• Instruction & Training

  • 8/1998 - Present, Rotation Student Supervision, UTHSCSA/UT College of Pharmacy/University of Incarnate Word
  • 1/1998 - Present, Post Graduate Rotation Supervision, UTHSCSA/UT College of Pharmacy/Armed Forces
  • 2/1997 - Present, 1855 Advanced Therapeutics

• Research & Grants

  Grants

  Private

  Funding Agency Novartis Title The Role of Inflammatory, Adipocytokines, and Insulin Signaling and Sensitivity in the Prevention of Type 2 Diabetes Mellitus in Hypertensive Subjects Treated with Valsartan Status Active Period 7/2005 - Present Role Co-Investigator Grant Detail The Role of Inflammatory, Adipocytokines, and Insulin Signaling and Sensitivity in the Prevention of Type 2 Diabetes Mellitus in Hypertensive Subjects Treated with Valsartan